mizoribine has been researched along with Leukocytopenia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akioka, K; Fujisawa, M; Fukuda, Y; Horimi, T; Ito, SI; Nakatani, T; Nishimura, K; Sugitani, A; Uchida, K; Ushigome, H; Yoshimura, N; Yuzawa, K | 1 |
Akiyama, T; Amada, N; Chikaraishi, T; Ishida, H; Takahara, S; Takahashi, K; Tanabe, K; Toma, H; Tomikawa, S; Uchida, K | 1 |
Inou, T; Kusaba, R; Kuzuhara, K; Otsubo, O; Sugimoto, H; Takahashi, I; Yamada, Y; Yamauchi, J | 1 |
Akiyama, N; Inou, T; Kusaba, R; Otubo, O; Sugimoto, H; Takahashi, I; Yamada, Y; Yamauchi, J | 1 |
Fukunishi, T; Ichikawa, Y; Ishibashi, M; Kokado, Y; Nagano, S; Sonoda, T; Takahara, S | 1 |
2 trial(s) available for mizoribine and Leukocytopenia
Article | Year |
---|---|
A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Basiliximab; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Japan; Kaplan-Meier Estimate; Kidney Transplantation; Leukopenia; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recombinant Fusion Proteins; Ribonucleosides; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2016 |
Clinical trial of bredinin in renal transplantation.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Female; Graft Survival; Humans; Kidney Transplantation; Leukopenia; Liver Diseases; Male; Middle Aged; Postoperative Complications; Ribonucleosides; Time Factors | 1981 |
3 other study(ies) available for mizoribine and Leukocytopenia
Article | Year |
---|---|
Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Basiliximab; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Prednisolone; Recombinant Fusion Proteins; Ribonucleosides; Viremia; Young Adult | 2016 |
Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukopenia; Male; Middle Aged; Ribonucleosides | 1981 |
Combined immunosuppression with low-dose cyclosporine, mizoribine, and prednisolone.
Topics: Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Humans; Kidney; Kidney Transplantation; Leukopenia; Liver Diseases; Prednisolone; Ribonucleosides | 1988 |